CRISPR Cancer Immunotherapy in CAR T Cells
If you’re interested in cancer, immunotherapy, or CRISPR, this project shows how visualization can make complex science easier to understand.
The Friedrich Lab studies how to improve CAR T cells for cancer immunotherapy. These engineered cells can attack tumors, but they don’t always last long enough in the body. Other immune cells, especially natural killer (NK) cells, can recognize and destroy them.
The lab uses CRISPR to solve this problem.
Researchers removed a receptor called B7H6 from the CAR T cells. Without this receptor, NK cells struggle to recognize and attack them. As a result, the engineered cells survive longer and continue fighting cancer more effectively.
This change creates a clear outcome: longer-lasting cells lead to stronger immunotherapy.
However, explaining this process can be difficult. Traditional diagrams often show the parts but don’t clearly explain how the system changes after CRISPR editing.
To improve communication, SciStories created a mechanism of action visualization. The design focuses on cause and effect. It shows how cells interact, what happens before the genetic change, and how the system improves after.

Simple visual cues guide the viewer. Arrows, spacing, and layout help explain how CRISPR changes cell behavior. This approach makes the science easier to follow without removing important details.
The visualization works because it stays clear and accurate. It simplifies the process, but it still reflects real biology and cancer immunotherapy. Viewers can quickly understand how modifying cells improves treatment.
This project also gives the lab a practical tool. They can use the same visualization across presentations, publications, and outreach, which strengthens how they communicate their research.
Overall, this work shows how CRISPR, cells, and immunotherapy come together in modern cancer research. It also highlights how strong visual communication can make advanced science more accessible without oversimplifying it.
